Christopher J. Sobecki, Director at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 102,445 shares at $2.25 ($246K) on 2019-09-13, disclosed to the SEC on 2019-09-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.25 | 601 | $1K | 0.5% |
| 2 | $2.27 | 200 | $454 | 0.2% |
| 3 | $2.28 | 500 | $1K | 0.5% |
| 4 | $2.30 | 400 | $920 | 0.4% |
| 5 | $2.31 | 1,600 | $4K | 1.5% |
| 6 | $2.32 | 1,000 |
| $2K |
| 0.9% |
| 7 | $2.33 | 1,000 | $2K | 0.9% |
| 8 | $2.34 | 3,500 | $8K | 3.3% |
| 9 | $2.35 | 600 | $1K | 0.6% |
| 10 | $2.36 | 1,200 | $3K | 1.1% |
| 11 | $2.37 | 2,206 | $5K | 2.1% |
| 12 | $2.38 | 9,784 | $23K | 9.4% |
| 13 | $2.38 | 1,396 | $3K | 1.4% |
| 14 | $2.39 | 1,396 | $3K | 1.4% |
| 15 | $2.39 | 14,338 | $34K | 13.9% |
| 16 | $2.40 | 9,450 | $23K | 9.2% |
| 17 | $2.40 | 200 | $481 | 0.2% |
| 18 | $2.41 | 8,112 | $20K | 7.9% |
| 19 | $2.41 | 200 | $482 | 0.2% |
| 20 | $2.42 | 1,000 | $2K | 1.0% |
| 21 | $2.42 | 1,000 | $2K | 1.0% |
| 22 | $2.42 | 9,943 | $24K | 9.8% |
| 23 | $2.43 | 5,225 | $13K | 5.2% |
| 24 | $2.44 | 400 | $974 | 0.4% |
| 25 | $2.44 | 15,158 | $37K | 15.0% |
| 26 | $2.44 | 400 | $976 | 0.4% |
| 27 | $2.45 | 2,400 | $6K | 2.4% |
| 28 | $2.46 | 5,200 | $13K | 5.2% |
| 29 | $2.46 | 100 | $247 | 0.1% |
| 30 | $2.47 | 3,336 | $8K | 3.3% |
| 31 | $2.47 | 100 | $247 | 0.1% |
| 32 | $2.48 | 100 | $248 | 0.1% |
| 33 | $2.48 | 300 | $744 | 0.3% |
| 34 | $2.48 | 100 | $248 | 0.1% |
| Total | $2.41 avg | 102,445 | $246K | 100% |
| Filing → |
| WTW | BUY | 2016-03-03 | $610K | — | Filing → |